Results 201 to 210 of about 44,033 (313)

Novel Drug‐Disease Modeling Framework for Oncology Benefit–Risk Evaluation: Application to Tusamitamab Ravtansine

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 2, February 2026.
ABSTRACT This study introduces a novel drug‐disease modeling framework designed to assess the benefit–risk balance of antibody‐drug conjugates (ADC) in oncology. The framework integrates dose levels, pharmacokinetics, tumor growth dynamics, progression‐free survival (PFS), and dose‐adjusted adverse events.
Marc Cerou   +8 more
wiley   +1 more source

Missing Value Imputation With Adversarial Random Forests—MissARF

open access: yesStatistics in Medicine, Volume 45, Issue 3-5, February 2026.
ABSTRACT Handling missing values is a common challenge in biostatistical analyses, typically addressed by imputation methods. We propose a novel, fast, and easy‐to‐use imputation method called missing value imputation with adversarial random forests (MissARF), based on generative machine learning, that provides both single and multiple imputation ...
Pegah Golchian   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy